Bioaccessibility of individual phenolic compounds in extra virgin argan oil after simulated gastrointestinal process

Bioaccessibility of individual phenolic compounds in extra virgin argan oil after simulated gastrointestinal process

Accepted Manuscript Bioaccessibility of individual phenolic compounds in extra virgin argan oil after simulated gastrointestinal process Ascensión Rue...

661KB Sizes 0 Downloads 61 Views

Accepted Manuscript Bioaccessibility of individual phenolic compounds in extra virgin argan oil after simulated gastrointestinal process Ascensión Rueda, Samuel Cantarero, Isabel Seiquer, Carmen Cabrera-Vique, Manuel Olalla PII:

S0023-6438(16)30590-4

DOI:

10.1016/j.lwt.2016.09.028

Reference:

YFSTL 5741

To appear in:

LWT - Food Science and Technology

Received Date: 3 February 2016 Revised Date:

12 September 2016

Accepted Date: 21 September 2016

Please cite this article as: Rueda, A., Cantarero, S., Seiquer, I., Cabrera-Vique, C., Olalla, M., Bioaccessibility of individual phenolic compounds in extra virgin argan oil after simulated gastrointestinal process, LWT - Food Science and Technology (2016), doi: 10.1016/j.lwt.2016.09.028. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT

Page 1 of 21

1

Bioaccessibility of individual phenolic compounds in extra

2

virgin argan oil after simulated gastrointestinal process

3

Ascensión Ruedaa*, Samuel Cantarerob, Isabel Seiquerc, Carmen Cabrera-

5

Viquea, Manuel Olallaa

6

a

7

de Granada, Granada, Spain

8

b

9

Universidad de Granada, Granada, Spain

RI PT

4

SC

Departamento de Nutrición y Bromatología. Facultad de Farmacia, Universidad

M AN U

Centro de Instrumentación Científica. Campus Universitario de Fuentenueva.

10

c

11

Experimental del Zaidín (CSIC), Armilla, Granada, Spain

Departamento de Fisiología y Bioquímica de la Nutrición Animal, Estación

12

*Corresponding author (phone number: +34-958240755; Fax: +34-958249577;

14

E-mail: [email protected])

17 18 19 20

EP

16

AC C

15

TE D

13

ACCEPTED MANUSCRIPT ABSTRACT

22

The bioaccessibility of individual phenolic compounds in extra virgin argan oil

23

was evaluated using an in vitro digestion method for first time. The analyses

24

were carried out by ultra-performance liquid chromatography-electrospray

25

ionisation tandem mass spectrometry in multiple reaction monitoring (UPLC-

26

ESI-MS/MS). Hydroxyphenylacetic acid (4245 µg/kg), ferulic acid (2478 µg/kg),

27

vanillin (2429 µg/kg) and 3,4-dihydroxybenzoic acid (2247 µg/kg) were the

28

mayor compounds identified in argan oil extracts. After the digestion process,

29

values of bioaccessibility of the different compounds varied from a minimum of

30

2% (hydroxyphenylacetic acid) to a maximum of 84% (p-coumaric acid), but

31

some such as caffeic acid became detectable, as a result from digestive

32

transformations. The results indicate that the phenolic compounds of the argan

33

oil are strongly affected during the digestive process, and bioaccessibility

34

should be taken into account when assessing polyphenol content of oils.

35

TE D

M AN U

SC

RI PT

21

Keywords

37

In vitro digestion, individual polyphenols, argan oil, UPLC

39 40 41 42

AC C

38

EP

36

43 44 45 46 2

ACCEPTED MANUSCRIPT 47 48 49

1. Introduction Virgin argan oil is a product obtained from roasted seeds of the fruit of

51

the argan tree Argania spinosa L. Skeels, which is endemic to SW Morocco.

52

This oil has been used by the Berber population for centuries due to its

53

sensorial and health-giving properties (Ahansal, Ben Sassi, Martini, Vaughan-

54

Martini, Walker & Boussaid, 2008). The presence of phenols and phytosterols in

55

argan oil has been associated with a cholesterol-lowering activity (Guillaume &

56

Charrouf 2011) and antidiabetic effects have been shown in rats (Bellahcen,

57

Mekhfi, Ziyyat, Legssyer, Hakkou, Aziz & Bnouham, 2012). In oils, polar lipids

58

contribute greatly to nutritional value due to specific anti-inflammatory activities

59

(Nasopoulou et al., 2014), but among the bioactive compounds present in virgin

60

argan oil, polyphenols play an important role, since their antioxidant activity is

61

related to cardioprotective (Pandey & Rizvi, 2009) and anti-inflammatory effects

62

(Rosillo, Alcaraz, Sánchez-Hidalgo, Fernández-Bolaños, Alarcón-de-la-Lastra

63

& Ferrándiz, 2014).

EP

TE D

M AN U

SC

RI PT

50

Polyphenols such as caffeic acid, oleuropein, vanillic acid, tyrosol, ferulic

65

acid, syringic acid, p-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, catechol,

66

resorcinol and 4-hydroxybenzyl have been identified in virgin argan oil (Charrouf

67

& Guillaume, 2007; Charrouf & Guillaume 2008), but his bioaccessibility has not

68

been evaluated yet. Gallic acid has reported bioactivities such as antineoplastic,

69

bacteriostatic, antimelanogenic and antioxidant properties. This molecule

70

showed anticancer properties in prostate carcinoma cells. p-Hydroxybenzoic

71

acid has been reported to have antioxidant activities against free radicals,

72

antimicrobial activities and antimutagenic properties. vanillic acid showed

AC C

64

3

ACCEPTED MANUSCRIPT 73

antisicking and anthelmintic activities, and is also able to suppress hepatic

74

fibrosis in chronic liver injury. Syringic acid show antioxidant, antibacterial and

75

hepatoprotective activities (Heleno, Martins, Queiroz & Ferreira, 2015). The concept of bioaccessibility refers to the fraction of a compound which

77

is released from the food matrix in the gastrointestinal tract and becomes

78

available for absorption (Heaney, 2001). The polyphenol’s beneficial effects can

79

only be truly effective if they reach the relevant tissues and exert their action at

80

a sufficient concentration to have a biological effect. The most widely used

81

procedure for screening polyphenolic compound bioaccessibility is the in vitro

82

static gastrointestinal method (Carbonell-Capella, Buniowska, Barba, Esteve &

83

Frígola, 2014). One of the most important methods to determine the

84

bioaccessibility was proposed by Miller to simulate human digestion and

85

absorption of dietary iron in the study of phenolic compound release. Over time

86

this method has been used by other authors with modifications and has been

87

employed in the screening of multiple foods (Gil-Izquierdo, Zafrilla & Tomás-

88

Barberán,

89

Rodríguez-Roque, Rojas-Graü, Elez-Martínez & Martín-Belloso, 2013). Some

90

authors found that gastric digestion increases polyphenolic concentration,

91

whereas the duodenal fraction significantly lessens polyphenolic content in

92

pomegranate juice, broccoli and gooseberry (Pérez-Vicente, Gil-Izquierdo &

93

García-Viguera, 2002; Chiang, Kadouh & Zhou, 2013; Vallejo, Gil-Izquierdo,

94

Pérez-Vicente & García-Viguera, 2004). The method used by Bermudez-Soto et

95

al. (2007) found that during intestinal digestion a significant decrease in

96

anthocyanins (43%) and flavonols (26%) was observed, whereas chlorogenic

97

acid increased (24%) in chokeberry. Separation and characterization of

98

phenolic compounds has been conducted in argan fruit pulp, in alimentary and

Pérez-Vicente,

Gil-Izquierdo

&

García-Viguera,

2002;

AC C

EP

2002;

TE D

M AN U

SC

RI PT

76

4

ACCEPTED MANUSCRIPT 99

cosmetic oil and in the press cake (Charrouf & Guillaime 2007; El Abbassi,

100

Khalid, Zbakh & Ahmad, 2014), but the analysis of individual phenolic

101

compounds after subjecting argan oil to an in vitro digestion process has not

102

been done yet. Due to the great interest of phenolic compounds, great efforts have been

104

made in the last years to provide a technique highly sensitive for their

105

determination, and methodologies such as gas chromatography, capillary

106

electrophoresis and high performance liquid chromatography (HPLC), among

107

others, have been applied (Carrasco-Pancorbo et al., 2005; Ignat et al., 2011).

108

The use of ultra-performance liquid chromatography (UPLC) decreases the time

109

needed for analysis (<20 minutes), improves the resolution and provides great

110

sensitivity, and this method coupled with a MS/MS technique, makes it easy to

111

detect a large number of compounds in a short time (Kartsova & Alekseeva,

112

2008).

TE D

M AN U

SC

RI PT

103

113

The aim of this study was to assess the bioaccessibility of individual

114

phenolic compounds in argan oil after an in vitro digestion method simulating

115

the

116

chromatography-electrospray ionisation tandem mass spectrometry (UPLC-ESI-

117

MS/MS) in multiple reaction monitoring (MRM) was used as an analytical

118

technique. The high sensitivity of this method enabled us to obtain low detection

119

limits.

EP

gastrointestinal

digestion

AC C

human

120 121

2. Materials and methods

122

2.1. Materials

123

2.1.1. Oils samples 5

process.

Ultra-performance

liquid

ACCEPTED MANUSCRIPT Five commercial samples labelled as extra virgin argan oil (acidity value

125

lower than 0.8 % oleic acid, Norme Marocaine, 2003), obtained from specialist

126

stores in Spain, were included in the study. The samples were produced in

127

Morocco and obtained by cold pressing. The oil samples were carefully handled

128

to avoid contamination and correctly stored and maintained at a temperature of

129

4 ºC until analysis.

130

2.1.2. Reagents and standards

RI PT

124

All chemicals were analytical reagent grade or higher purity. Ultrapure

132

water was obtained from a Milli-Q purification system (Millipore, Bedford, MA).

133

Methanol and acetonitrile were supplied by Sigma-Aldrich (LC-MS Ultra

134

Chromasolv® Sigma Chemical Co., St. Louis, MO). Sodium bicarbonate,

135

sodium carbonate and hydrochloric acid (37%) were purchased from Merck

136

(Merck, Darmstadt, Germany). The commercial phenolic compound standards

137

used were oleuropein, p-coumaric acid, o-coumaric acid, 4-hydroxyphenylacetic

138

acid, quercetin, vanillin, gallic acid, 3,4-dihydroxybenzoic acid, caffeic acid and

139

syringic acid, all purchased from Sigma-Aldrich. Ferulic acid, tyrosol, luteolin

140

and vanillic acid were purchased from Fluka Chemicals (Madrid, Spain). Stock

141

standard solutions were prepared by dissolving each phenolic compound at a

142

concentration of 10 mg/mL in methanol, and the resulting solution was then

143

stored at -18 °C.

144

2.2. Methods

145

2.2.1. In vitro digestion

AC C

EP

TE D

M AN U

SC

131

146

The in vitro digestion procedure (Fig. 1) was performed according to the

147

method described by Mesías et al. (2009), slightly modified. The method

148

consists of two sequential steps; an initial pepsin/HCl digestion to simulate 6

ACCEPTED MANUSCRIPT gastric conditions, followed by a digestion with bile salts/pancreatin to simulate

150

duodenal digestion. Four grams of oil samples were mixed with 9 mL of

151

bidistilled deionised water and sonicated (Vibracell VCX 130, Sonics &

152

Materials INC, Danbury, Connecticut, USA). The pH was adjusted to 2 using

153

HCl 1N. Pepsin (Sigma-Aldrich, Milan, Italy) was added to a final concentration

154

of 0.05 g of pepsin / g sample and the samples were incubated in a shaking

155

water bath (Bunsen, Madrid, Spain) at 110 oscillations/min, at 37 °C for 2 hours.

156

For intestinal digestion, the pH was raised to 6 with NaHCO3 (1 M) dropwise,

157

and 2.5 mL of a mixture of 0.4 g of pancreatin + 0.25 g of bile salts (Sigma-

158

Aldrich, Milan, Italy) were added. The final pH was adjusted to 7 with NaHCO3

159

(1 M) and the samples were incubated in a shaking water bath (110 rpm; 37 °C)

160

for 2 hours. After gastrointestinal digestion, the digestive enzymes were

161

inactivated by heat treatment for 4 min at 100 ºC in a polyethylenglycol bath.

162

The samples were then cooled by immersion in an ice bath and centrifuged at

163

10.000 rpm (Sorvall RC 6 Plus centrifuge, Thermo Scientific, Madrid, Spain) for

164

30 min at 4 °C. The supernatants were carefully separated to obtain the

165

bioaccessible fraction, which was filtered using Vivaspin® 2 ml Centrifugal

166

Concentrator to remove the potential presence of protein, and then freeze-dried.

167

Lyophilized samples were dissolved in 3 ml of methanol / acetonitrile 50% (v / v)

168

for chromatographic analysis. Throughout the process, the samples were

169

protected from light, cooled with an ice bath and submitted to sonication before

170

each step.

171

2.2.3. Phenolic extract

AC C

EP

TE D

M AN U

SC

RI PT

149

172

A liquid–liquid extraction adaptation technique (Montedoro, Servili,

173

Baldioli & Miniati, 1992) was used to determine individual phenolic compounds.

7

ACCEPTED MANUSCRIPT 15 g of oil was mixed with 10 ml of methanol 80% v/v, the mixture was shaken

175

in an orbital shaker (3005 GFL®, Grossburgwedel, Germany) for 1 hour and

176

centrifuged (Hettich zentrifugen Universal 320, Buckinghamshire, England) at

177

8000 rpm for 15 minutes. The supernatant was removed and the process was

178

repeated twice. Using a rotary evaporator (R-215, Buchi Switzerland), a

179

gelatinous residue was obtained, which was dissolved in 5 ml of methanol and

180

filtered through a 0.45 µm Millipore syringe filter.

181

2.2.4. UPLC analysis of polyphenols

SC

182

RI PT

174

Analyses of polyphenols were carried out in chemical extracts and in bioavailable

fractions

obtained

after

the

in

vitro

digestion

of

oils.

184

Chromatographic analysis of the polyphenols was performed in the Scientific

185

Instrumentation Centre of the University of Granada using an Acquity UPLC H-

186

Class with MS detection (Waters, Barcelona, Spain) and separations were

187

achieved using an Acquity UPLC HSS T3 column (100 mm x 2.1 mm, 1.8 µm

188

particle size).

TE D

M AN U

183

Chromatographic separation was carried out using a gradient elution with

190

water + 0.5% acetic acid as eluent A and acetonitrile +0.5% acetic acid as

191

eluent B. The flow rate was 650 µL/min, the column was maintained at 45 ºC

192

and the injection volume was 10 µL. Gradient conditions were as follows: initial

193

mobile phase, 99% (A), which was linearly decreased to 70% (A) within 10.0

194

min and to 5% within 12.0 min. Finally, it was returned to 99% in 0.1 min and

195

maintained for 2.9 min to equilibrate the column. Total run time was 15 min.

196

Mass spectrometry analysis was carried out using a Waters XEVO TQ-S

197

tandem quadrupole mass spectrometer. The instrument was operated using

198

ESI ionisation in negative ion mode. Data acquisition was performed using

199

MassLynx 4.1 software with the QuanLynx program (Waters). For MS/MS

AC C

EP

189

8

ACCEPTED MANUSCRIPT detection, the ionisation source parameters in negative mode were the

201

following: capillary voltage 2.00 kV and cone voltage 10 V; the source

202

temperature was 100 °C and the desolvation temperature, 300 °C. The cone

203

gas (nitrogen) and desolvation gas (also nitrogen) were set at flow rates of 150

204

and 500 L/h, respectively.

RI PT

200

The conditions used were adapted from previous papers (Goh & Gledhill,

206

2011), seeking to obtain high sensitivity and to reduce analysis time. The

207

IntelliStart™ Software was used to develop MRM acquisition methods for the 14

208

phenolic compounds targeted in this analysis. Standard solutions of 10 mg/L of

209

each phenolic compound at a flow rate of 10 µL/min were infused at first and

210

then combined with the mobile phase flow. The collision voltage was optimised,

211

selecting the most sensitive transition for quantification. Some phenolic

212

compounds presented initially close retention times, but optimization of the

213

methods allowed the subsequent identification due to their different transitions.

214

Quantification of the samples was performed against a calibration curve for

215

each of the polyphenol analytes in solution. A chromatogram of digested argan

216

oil sample is shown in Fig. 2 according to the conditions established in the

217

methodology.

M AN U

TE D

EP

Table 1 shows the parameters optimised for quantification using MRM,

AC C

218

SC

205

219

the calibration curves obtained, the recovery percentages and the limits of

220

detection and of quantification (LOD and LOQ, respectively) obtained for each

221

compound. After optimising the transitions, calibration curves were constructed

222

for each compound, using various concentration ranges, but always including at

223

least 5 different concentration points. LOD was determined by using a signal-to-

224

noise ratio of 3, and LOQ, by using a signal-to-noise ratio of 10.

9

ACCEPTED MANUSCRIPT The R2 values were greater than 0.9901 for all the compounds used, and

226

the detection limits ranged from 0.07 µg/kg for hydroxyphenylacetic acid to 0.26

227

µg/kg for quercetin. The recovery (%) was calculated as the percentage from

228

the known amount of standard added to a refined vegetable oil. Analyses were

229

carried out in triplicate.

RI PT

225

230 231

3. Results and discussion

In this experimental study, we first determined the initial content of

233

polyphenols. A total of 14 phenolic compounds were analysed, structures of

234

which are depicted as supplementary material (S1). Quercetin and oleuropein

235

were not detected before or after the in vitro digestion process. 11 compounds

236

were detected and quantified in argan oil extracts (Fig. 3), being the major ones

237

hydroxyphenylacetic acid (4245 µg/kg), ferulic acid (2478 µg/kg), vanillin (2429

238

µg/kg) and 3,4-dihydroxybenzoic acid (2247 µg/kg). Other compounds that have

239

been quantified in argan oil extracts are vanillic acid (1190 µg/kg) and tyrosol

240

(2048 µg/kg); these polyphenols were identified as major components of argan

241

oil by Chaurrof & Guillaume (2007). Khallouki et al. (2003) measured the

242

following quantities in commercial argan oil: vanillic acid 123 µg/kg; syringic acid

243

68 µg/kg, tyrosol 52 µg/kg. These levels are lower than those obtained in our

244

study, although the concentration of ferulic acid was slightly higher (3470

245

µg/kg). Aidoud et al. (2014) also measured lower quantities than those found in

246

our study with respect to vanillic acid (67 µg/kg), syringic acid (37 µg/kg) and

247

tyrosol (12 µg/kg), and higher levels of ferulic acid (3147 µg/kg).

AC C

EP

TE D

M AN U

SC

232

248

Some polyphenols have been identified in the leaves and the fruit pulp of

249

the argan tree (Charrouf & Guillaume, 2008; Aidoud, Ammouche, Garrido &

250

Rodriguez,

2014).

In

the

press

cake,

3,4-dihydroxybenzoic

acid,

410

ACCEPTED MANUSCRIPT 251

hydroxyphenylacetic acid and vanillin have been identified (Joguet & Maugard,

252

2013). The simulation of digestion is widely used in many fields of food and

254

nutritional science, as human trials are often expensive, require considerable

255

resources and may be ethically questionable (Lin, Shi, Wang &Shen, 2008). In

256

vitro models of digestion provide a useful alternative to animal and human

257

models and the results supplied are fast and accurate (Coni et al., 2000).

RI PT

253

In our study, polyphenol concentrations generally decreased during the

259

simulated in vitro gastrointestinal digestion (Fig. 3). The highest levels of

260

polyphenols found in the bioavailable fraction of argan oil were vanillic acid, p-

261

coumaric acid and o-coumaric acid. Polyphenols shown a considerable

262

structural diversity which largely influences their bioaccessibility; it has been

263

shown that phenols may undergo structural modifications during the digestion

264

process that may reduce their bioaccessible fraction, mainly due to changes of

265

pH and interactions with other compounds, which differ depending on their

266

chemical structure (Dinnella et al., 2007). However, some compounds became

267

detectable or their concentration increased slightly after the digestion process,

268

as caffeic acid. On accordance, previous assays concerning transformations of

269

phenolic compounds during in vitro digestion of foods have shown that caffeic

270

acid is detected after the digestion process, but not before (Tarko et al., 2009).

271

Caffeic acid may derive from the hydrolysis of chlorogenic acid in the small

272

intestine (Sato et al., 2011), but early studies show that it also may results of the

273

conversion of p-coumaric acid (Sato, 1969). Thus, in argan oil digested, it may

274

be hypothesized that caffeic acid could come from p-coumaric acid.

AC C

EP

TE D

M AN U

SC

258

11

ACCEPTED MANUSCRIPT Fig. 4 shows the bioaccessibility of the different polyphenols (calculated

276

as the percentage from the initial quantity measured in the chemical extracts),

277

for the oils analysed. With the exception of luteolin, which was detected in the

278

chemical extracts but not after the in vitro digestion, values of bioaccessibility

279

varied largely, from 2% (hydroxyphenylacetic acid) to 84 % (p-coumaric acid). A

280

value of 100% was assigned to caffeic acid, as it was only detected in the

281

bioaccessible fraction. The largest decreases (expressed in percentage of

282

reduction from the initial quantity) were observed in the following compounds:

283

syringic

284

hydroxyphenylacetic acid 98%; vanillin 95% and ferulic acid 94%. These losses

285

were greater than those reported by Dinnella et al. (2007), who describe that

286

bioaccessibility of olive oil phenols vary from 37 to 90%. Other studies have

287

indicated that the process of digestion reduces phenolic content by 47-62%

288

(Minekus et al., 2014). It is possible that the pancreatin digestion liberates

289

compounds able to associate with phenolic compounds (Joguet & Maugard,

290

2013). During gastrointestinal digestion, polyphenols may either interact with

291

other food constituents (e.g., chelation of ions), be further degraded (such as

292

anthocyanins in the small intestine), or metabolised, such as by hydrolysis via,

293

e.g., deglycosylation or cleavage by esterases (Hura, Limb, Decker &

294

McClements, 2011).

3,4-dihydroxybenzoic

acid

95%;

SC

93%;

tyrosol

91%;

EP

TE D

M AN U

acid

AC C

295

RI PT

275

To our knowledge, there is a lack of information concerning concentration

296

of individual polyphenols after in vitro digestion in argan oil, and only

297

bioaccessibility of total phenol content and antioxidant activity has been recently

298

reported by our research group (Seiquer et al., 2015).

299

12

ACCEPTED MANUSCRIPT 4. Conclusions

301

The analysis of phenolic compounds after subjecting argan oil to an in

302

vitro digestion process was performed for the first time. In general, the

303

polyphenol concentration in the bioaccessible fraction of the argan oil was lower

304

than in the initial extract of the oil. In the bioaccessible fraction, argan oil contain

305

quantities of 3,4-dihydroxybenzoic acid, tyrosol, vanillic acid, caffeic acid,

306

syringic acid, p-coumaric acid, o-coumaric acid and ferulic acid.

RI PT

300

Polyphenols are highly sensitive to the mild alkaline conditions in the

308

small intestine and a great proportion of these compounds can be transformed

309

into other unknown and/or undetected structural forms with different chemical

310

properties and, consequently, different bioaccessibility, bioavailability and

311

biological activity. Intestinal transformations of polyphenols seem to occur

312

during the digestion process of argan oil, leading to the release of the

313

compounds from the food matrix. However, these compounds could be

314

hydrolysed depending on the intestinal conditions.

TE D

M AN U

SC

307

Decreases or increases of phenolic compounds in the bioaccessible

316

fractions of oils may take place, as it has been observed in the present study.

317

The results obtained indicate that only a minor fraction of argan oil polyphenols

318

may be considered bioavailable for subsequent absorption by the intestinal

319

cells. In any case, to better understand the transformation of argan oil

320

polyphenols during the digestion process more extensive study will be required,

321

to determine the presence of new metabolites.

AC C

EP

315

322 323

Conflict of interest

13

ACCEPTED MANUSCRIPT 324

The Authors declare that they have no conflict of interest.

325

Acknowledgements

327

This work was supported by the research group AGR141 of Junta de Andalucía

328

of University of Granada.

RI PT

326

AC C

EP

TE D

M AN U

SC

329

14

ACCEPTED MANUSCRIPT REFERENCES

331

Ahansal, L., Ben Sassi, A., Martini, A., Vaughan-Martini, A., Walker G. &

332

Boussaid, A. (2008). Biodiversity of yeasts isolated from the indigenous

333

forest of Argan (Argania spinosa (L.) Skeels) in Morocco. World Journal of

334

Microbiology and Biotechnology, 24, 777–782.

RI PT

330

Aidoud, A., Ammouche, A., Garrido, M. & Rodriguez, A. B. (2014). Effect of

336

lycopene-enriched olive and argan oils upon lipid serum parameters in

337

Wistar rats. Journal of the Science of Food and Agriculture, 94, 2943-

338

2950.

M AN U

SC

335

Bellahcen, S., Mekhfi, H., Ziyyat, A., Legssyer, A., Hakkou, A., Aziz, M. &

340

Bnouham, M. (2012). Prevention of chemically induced diabetes mellitus

341

in experimental animals by virgin argan oil. Phytotherapy Research, 26,

342

180-185.

TE D

339

Bermúdez-Soto, M. J., Tomás-Barberán, F. A. & García-Conesa, M. T. (2007).

344

Stability of polyphenols in chokeberry (Aronia melanocarpa) subjected to

345

in vitro gastric and pancreatic digestion. Food Chemistry, 102, 865–74.

347 348 349 350

351 352

Carbonell-Capella, J. M., Buniowska, M., Barba, F. J., Esteve, M. J. & Frígola,

AC C

346

EP

343

M. (2014). Analytical methods for determining bioavailability and bioaccessibility of bioactive compounds from fruits and vegetables: a review. Comprehensive Reviews in Food Science and Food Safety, 13, 155-171.

Carrasco-Pancorbo, A., Cerretani, L., Bendini, A., Segura-Carretero, A., Gallina-Toschi,

T.

&

Fernández-Gutierrez,

15

A

(2005).

Analytical

ACCEPTED MANUSCRIPT 353

determination of polyphenols in olive oils. Journal of Separation Science,

354

28, 837–858. Charrouf, Z. & Guillaume, D. (2008). Argan oil: Occurrence, composition and

356

impact on human health. European Journal of Lipid Science and

357

Technology, 110, 632–636.

358 359

RI PT

355

Charrouf, Z. & Guillaume, D. (2007). Phenols and polyphenols from Argania spinosa, American Journal of Food Technology, 2, 679–683.

Chiang, C. J., Kadouh, H. and Zhou, K. (2013). Phenolic compounds and

361

antioxidant properties of gooseberry as affected by in vitro digestion. LWT-

362

Food Science and Technology, 51, 417–422.

M AN U

SC

360

Coni, E., Di Benedetto, R., Di Pasquale, M., Masella, R., Modesti, D., Attei, R.,

364

et al. (2000). Protective effect of oleuropein, and olive oil biophenol, on low

365

density lipoprotein oxidizability in rabbits, Lipids, 35, 45–54.

366

Dinnella,

TE D

363

C.,

Minichino,

P.,

D’Andrea,

A.M.

&

Monteleone.

(2007).

Bioaccessibility and antioxidant activity stability of phenolic compounds

368

from extra-virgin olive oils during in vitro digestion. Journal of Agriculture

369

and Food Chemistry, 55, 8423-8429.

AC C

EP

367

370

El Abbassi, A., Khalid, N., Zbakh, H. & Ahmad, A. (2014) Physicochemical

371

characteristics, nutritional properties, and health benefits of argan oil: a

372

review. Critical Reviews in Food Science and Nutrition, 11, 1401-1414.

373

Gil-Izquierdo, A., Zafrilla, P. & Tomás-Barberán, F. A. (2002). An in vitro method

374

to simulate phenolic compound release from the food matrix in the

375

gastrointestinal tract. European Food Research and Technology, 214,

376

155–159. 16

ACCEPTED MANUSCRIPT 377

Goh, E. & Gledhill, A. (2011). Analysis of polyphenols in fruit juices using

378

ACQUITY UPLC H-Class with UV and MS detection Waters Pacific,

379

Singapore, Waters Corporation, Manchester, UK.

381

Guillaume, D. & Charrouf, Z. (2011). Argan Oil. Alternative Medicine Review, 16, Number 3.

RI PT

380

Heleno, S. A., Martins, A, Queiroz, M. J. & Ferreira, I. (2015). Bioactivity of

383

phenolic acids: metabolites versus parent compounds: a review. Food

384

Chemistry, 173, 501-513.

SC

382

Hura, S. J., Limb, B. O., Decker, E. A. & McClements, D. J. (2011). In vitro

386

human digestion models for food applications. Food Chemistry, 125, 1–12.

387

Ignat, I., Volf, I., & Popa, V. I. (2011). A critical review of methods for

388

characterisation of polyphenolic compounds in fruits and vegetables. Food

389

Chemistry, 126, 1821-1835.

TE D

M AN U

385

Joguet, N. & Maugard, T. (2013). Characterization and quantification of phenolic

391

compounds of Argania spinosa leaves by HPLC-PDA-ESI-MS analyses

392

and their antioxidant activity. Chemistry of Natural Compounds, 48, 1069–

393

1071.

AC C

EP

390

394

Kartsova, L. A. & Alekseeva, A. V. (2008). Chromatographic and electrophoretic

395

methods for determining polyphenol compounds. Journal of Analytical

396

Chemistry , 63, 1024–1033.

397

Khallouki, F., Younos, C., Soulimani, R., Oster, T. Charrouf, Z., Spiegelhalder,

398

B., et al. (2003). Consumption of argan oil (Morocco) with its unique profile

399

of fatty acids, tocopherols, squalene, sterols and phenolic compounds

17

ACCEPTED MANUSCRIPT 400

should confer valuable cancer chemopreventive effects. European Journal

401

of Cancer Prevention, 12, 67–75.

402 403

Lin, Y., Shi, R., Wang, X. & Shen, H. M. (2008). Luteolin, a flavonoid with potential for cancer prevention and therapy. Current Cancer Drug Targets, 8, 634–646.

405

Mesías, M., Seiquer, I. & Navarro, M. P. (2009). Influence of diets rich in

406

Maillard reaction products on calcium bioavailability. Assays in male

407

adolescents and in Caco-2 cells. Journal of Agricultural and Food

408

Chemistry, 57, 9532–9538.

M AN U

SC

RI PT

404

409

Minekus, M., Alminger, M., Alvito, P., Balance, S., Bohn, T., Bourlieu, C., et al.

410

(2014). A standardised static in vitro digestion method suitable for food -

411

an international consensus. Food & Function, 5, 1113–1124. Montedoro, G., Servili, M., Baldioli, M. & Miniati, E. (1992). Simple and

413

hydrolyzable phenolic compounds in virgin olive oil. Their extraction,

414

separation, and quantitative and semiquantitative evaluation by HPLC.

415

Journal of Agricultural and Food Chemistry, 40, 1571–1576.

417 418 419

420 421

EP

Nasopoulou, C., Karantonis, H. C., Detopoulou, M., Demopoulos, C. A., &

AC C

416

TE D

412

Zabetakis, I. (2014). Exploiting the anti-inflammatory properties of olive (Olea europaea) in the sustainable production of functional food and neutraceuticals. Phytochemistry Reviews 13, 445–458.

Norme Marocaine (2003). Service De Normalisation Industrielle Marocaine Huile d ‘argane. Spécifications. Rabat, NM 08.5.090.

18

ACCEPTED MANUSCRIPT 422

Pandey, K. B. & Rizvi, S. I. (2009).Plant polyphenols as dietary antioxidants in

423

human health and disease. Oxidative Medicine and Cellular Longevity, 2,

424

270–278. Pérez-Vicente, A., Gil-Izquierdo, A. & García-Viguera, C. (2002). In vitro

426

gastrointestinal digestion study of pomegranate juice phenolic compounds,

427

anthocyanins, and vitamin C. Journal of Agricultural and Food Chemistry,

428

50, 2308–2312.

RI PT

425

Rodríguez-Roque, M. J., Rojas-Graü, M. A., Elez-Martínez, P. & Martín-Belloso,

430

O. (2013). Soymilk phenolic compounds, isoflavones and antioxidant

431

activity as affected by in vitro gastrointestinal digestion. Food Chemistry,

432

136, 206–212.

M AN U

SC

429

Rosillo, M. Á., Alcaraz, M. J., Sánchez-Hidalgo, M., Fernández-Bolaños, J. G.,

434

Alarcón-de-la-Lastra, C. & Ferrándiz, M. L. (2014). Anti-inflammatory and

435

joint protective effects of extra-virgin olive-oil polyphenol extract in

436

experimental arthritis. The Journal of Nutritional Biochemistry, 25, 1275–

437

1281.

EP

TE D

433

Sato, M. (1969). The conversion by phenolase of p-coumaric acid to caffeic acid

439

with special reference to the role of ascorbic acid. Phytochemistry, 8, 353-

440

AC C

438

362.

441

Sato, Y., Itagaki, S., Kurokawa, T., Ogura, J., Kobayashi, M., Hirano, T.,

442

Sugawara, M. & Iseki, K. (2011). In vitro and in vivo antioxidant properties

443

of

444

Pharmaceutics 403, 136–138.

chlorogenic

acid

and

caffeic

19

acid.

International

Journal

of

ACCEPTED MANUSCRIPT 445

Seiquer, I., Rueda, A., Olalla, M & Cabrera-Vique, C. (2015). Assessing the

446

bioavailability of polyphenols and antioxidant properties of extra virgin

447

argan oils by simulated digestion and Caco-2 cell assays. Comparative

448

study with extra virgin olive oil. Food Chemistry, 188, 496-503. Tarko, T., Duda-Chodak, A.,

Sroka, P. Satora, P. & Michalik, J. (2009).

RI PT

449 450

Transformation of Phenolics in Alimentary Tract, Food Technology and

451

Biotechnology, 47, 456–463

Vallejo, F., Gil-Izquierdo, A., Pérez-Vicente, A. & García-Viguera, C. (2004). In

453

vitro gastrointestinal digestion study of broccoli inflorescence phenolic

454

compounds, glucosinolates, and vitamin C. Journal of Agricultural and

455

Food Chemistry, 52,135–138.

M AN U

SC

452

AC C

EP

TE D

456

20

ACCEPTED MANUSCRIPT 457

458

Figure captions.

459

Figure 1. Scheme of the in vitro digestion process applied to the oil samples.

460

Figure 2. UPLC–MS/MS chromatogram obtained from the digested argan oil

463

RI PT

462

sample.

Figure 3. Content of phenolic compounds in extra virgin argan oil before (oil extract) and after (digested oil) the digestion process.

SC

461

Figure. 4. Bioaccessibility of different polyphenols in argan oil (calculated as the

465

percentage from the initial quantity in the chemical extracts). 1: Gallic acid;

466

2: 3,4-Dihydroxybenzoic acid; 3: Tyrosol; 4: Hydroxyphenylacetic acid; 5:

467

Vanillic acid; 6: Caffeic acid; 7: Syringic; 8: Vanillin; 9: p-coumaric; 10:

468

Ferulic acid; 11: o-coumaric; 12: Quercetin; 13: Oleuropein; 14: Luteolin.

TE D EP AC C

469

M AN U

464

21

ACCEPTED MANUSCRIPT

Table 1

RT (min)

Calibration curvesa

Collision

LOD

LOQ

Recovery

voltage

energy

(µg/kg)

(µg/kg)

(%)

(V)

(eV)

0.47

96.5

y = 510255x - 43456.9

Cone

Transition

1.82

22.0

168.93 - 125.03

0.14

3, 4-Dihydroxybenzoic acid

4.25

30.0

152.93 - 53.08

24.0

0.09

0.31

99.0

y = 11961.3x - 819.205

Tyrosol

4.18

30.0

136.91 - 106.15

18.0

0.09

0.31

97.8

y = 2156.5x - 157.84

Hydroxyphenylacetic acid

4.50

30.0

150.95 - 79.09

18.0

0.07

0.24

96.4

y = 149507x - 11517

Vanillic acid

4.65

26.0

166.95 - 91.03

18.0

0.10

0.34

99.2

y = 30266.7x - 2551.55

Caffeic acid

4.92

10.0

178.95 - 135.05

14.0

0.07

0.22

98.3

y = 792138x - 57835.7

Syringic acid

5.23

12.0

197.08 - 167.03

18.0

0.05

0.17

96.6

y = 105523x - 7423.28

Vanillin

7.42

18.0

150.89 - 92.06

20.0

0.07

0.25

97.7

y = 68054.1x - 5533.4

p-Coumaric acid

5.95

18.0

162.95 - 119.06

28.0

0.11

0.39

98.4

y = 31614.3x - 3039.84

Ferulic acid

7.15

8.0

193.03 - 106.04

22.0

0.08

0.26

98.0

y = 2830.29x - 317.702

o-Coumaric acid

5.92

28.0

162.95 - 93.06

24.0

0.11

0.39

97.0

y = 31681.8x - 3026.2

Oleuropein

9.05

Luteolin

10.09

Quercetin

10.07

AC C

EP

TE D

M AN U

Gallic acid

a

14.0

SC

Phenolic compound

RI PT

Retention time (RT), MS/MS parameters of the selected phenolic compounds and analytical parameters for the UPLC method.

2.0

539.34 - 275.16

22.0

0.02

0.08

99.8

y = 4460.53x - 99.2215

74.0

285.08 - 133.01

38.0

0.09

0.31

98.5

y = 844.103x - 88.224

2.0

301.14 - 151.01

24.0

0.26

0.86

98.3

y = 30.596x - 7.474

Calibration ecuation y = ax + b; y = área, x = Compound concentration.

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

ACCEPTED MANUSCRIPT 3, 4-Dihydroxybenzoic acid

Hydroxyphenylacetic acid

RI PT

Vanillin

Tyrosol

Vanillic acid

M AN U

Gallic acid

SC

Caffeic acid

TE D

o-Coumaric acid

EP

Oleuropein

AC C

Quercetin

Luteolin

Syringic acid

Ferulic acid

p-Coumaric acid

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

ACCEPTED MANUSCRIPT Highlights The UPLC-ESI-MS/MS method of polyphenol analysis was applied.

2.

11 compounds were quantified in argan oil before and after digestion.

3.

The digestive process strongly affects the polyphenol content in argan oil.

4.

Only a minor fraction of oil polyphenols may be considered bioavailable.

AC C

EP

TE D

M AN U

SC

RI PT

1.